Eisai's New Drug Approval for Fycompa for Adjunctive Treatment of Partial Onset Seizures in China
- Written by ACN Newswire - Press Releases
TOKYO, Oct 15, 2019 - (JCN Newswire) - Eisai Co., Ltd. has announced that Eisai received a New Drug Approval for its in-house discovered and developed antiepileptic drug (AED) Fycompa (perampanel) from the China National Medical Products Administration (NMPA) for use in an adjunctive treatment of partial onset seizures (with or without
Read more //?#